Delivery Order SPE2DB24D2100-SPE2DB24FBDBU
Award Date
8/19/24
Potential Completion Date
8/20/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Cyclosporine 0.05% eye emulsion products to the U.S. government. The Delivery Order, valued at $1,845.39, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on May 20, 2024, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to...
This federal contract award, valued at $12,174.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a pharmaceutical product, to support various government agencies and healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 13, 2024. This award is not associated with a set-aside program. As a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,118.37 Firm Fixed Price Delivery Order is for the supply of Cyclosporine 0.05% Eye Emulsion, a pharmaceutical product used for ophthalmic applications. The contract has an ultimate completion date of August 28, 2024 and was awarded on August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor in the United States, has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.16 firm fixed price delivery order is for the supply of 4565747846 ! CYCLOSPORINE 0.05% EYE EMULSION 30S. The contract has a period of performance through September 11, 2024 and was awarded on September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,960.66 delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a pharmaceutical product used to treat various eye conditions. The contract has an ultimate completion date of August 13, 2024 and utilizes a Firm Fixed Price pricing structure. Amerisourcebergen, a major pharmaceutical distributor in the United States,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,534.29 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product. The contract has an ultimate completion date of March 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,919.03 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% Eye Emulsion, a medication used to treat certain eye conditions. The award is not designated as a set-aside and has an ultimate completion date of January 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,333.59 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical medication used in the treatment of various eye conditions. The contract has a period of performance through June 8, 2023 and does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $5,718.78 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion medication, with a period of performance through May 1, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cyclosporine 0.05% eye emulsion. The $5,541.70 firm fixed-price delivery order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities,...